New precompetitive paradigms: Focus on cardiac safety
No abstract is available. To read the body of this article, please view the Full Text online.
To access this article, please choose from the options below
PII: S0002-8703(09)00155-0
doi:10.1016/j.ahj.2009.02.021
© 2009 Mosby, Inc. All rights reserved.
Refers to article:
- Assessing proarrhythmic potential of drugs when optimal studies are infeasible
